Editorial ArticleClinical Diagnostics
CLINICAL24: MicrosensDx and Imperial College London develop revolutionary sepsis risk test
Join the CEO of MicrosensDx, Simon Walker, for a Q&A surrounding his collaboration with The Mayr Group at Imperial College London to develop a new sepsis test
